Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Toronto Immune and Digestive Health Institute (TIDHI), operating for research and corporate purposes as TIDHI Innovation Inc., is an integrative, multi-disciplinary medical center and clinical research institute based in Toronto, Canada. Founded by global gastroenterology expert Dr. Mark S. Silverberg, the institute specializes in providing advanced, holistic care for patients with chronic digestive and immune disorders, particularly inflammatory bowel disease (IBD), Crohn's disease, and ulcerative colitis. In addition to offering comprehensive clinical services such as endoscopy, colonoscopy, and personalized nutrition programs, TIDHI serves as a prominent clinical trial site, collaborating with major pharmaceutical companies like Janssen and Roche to evaluate novel therapeutics. The institute also develops and evaluates its own patient-centered interventions, such as the Healing Circuits structured mental health support model designed to address anxiety and depression in IBD patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TIDHI Innovation.